Resultados da busca - Michael Lattanzi
- Mostrando 1 - 3 resultados de 3
-
1
Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy por Michael Lattanzi, Yesung Lee, Danny Simpson, Una Moran, Farbod Darvishian, Randie H. Kim, Eva Hernando, David Polsky, Douglas Hanniford, Richard L. Shapiro, Russell S. Berman, Anna C. Pavlick, Melissa Wilson, Tomas Kirchhoff, Jeffrey S. Weber, Judy Zhong, Iman Osman
Publicado em 2018Artigo -
2
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma por Anna C. Pavlick, Ana-Belén Blázquez, Marcia Meseck, Michael Lattanzi, Patrick A. Ott, Thomas U. Marron, Rose Marie Holman, John Mandeli, Andres Μ. Salazar, Christopher B. McClain, Gustavo Giménez, Sreekumar Balan, Sacha Gnjatic, Rachel Lubong Sabado, Nina Bhardwaj
Publicado em 2019Artigo -
3
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial por Samuel A. Funt, Michael Lattanzi, Karissa Whiting, Hikmat Al‐Ahmadie, Colleen Quinlan, Min Yuen Teo, Chung‐Han Lee, David H. Aggen, Danielle Elise Zimmerman, Deaglan Joseph McHugh, Arlyn Apollo, Trey Durdin, Hong Truong, Jeffrey M. Kamradt, Maged Khalil, Bradley W. Lash, Irina Ostrovnaya, Asia S. McCoy, Grace Hettich, Ashley Marie Regazzi, Marwah Jihad, Neha Ratna, Abigail Boswell, Kaitlyn Francese, Yuanquan Yang, Edmund Folefac, Harry W. Herr, S. Machele Donat, Eugene J. Pietzak, K. Eugene, Timothy F. Donahue, Alvin C. Goh, William C. Huang, Dean F. Bajorin, Gopa Iyer, Bernard H. Bochner, Arjun Vasant Balar, Amir Mortazavi, Jonathan E. Rosenberg
Publicado em 2022Artigo
Ferramentas de busca:
Assuntos relacionados
Immunotherapy
Medicine
Cancer
Cancer research
Internal medicine
Melanoma
Oncology
Adjuvant
Antibody
Antigen
Atezolizumab
Avidity
Bladder cancer
Breast cancer
CD8
Cancer immunotherapy
Chemotherapy
Cisplatin
Clinical endpoint
Clinical trial
Cohort
Confidence interval
Cystectomy
Epidemiology
Gastroenterology
Gemcitabine
Hazard ratio
Histology
Immune system
Immunology